The descriptive epidemiology of type 2 diabetes in the United Kingdom from 2004 to 2021
Currie, C. J.
Show abstract
PurposeTo provide contemporary estimates of the incidence and prevalence of type 2 diabetes in the UK. MethodsData from UK primary care (CPRD) were analyzed using an automated, analytical platform that produces validated, rapid analytics-Livingstone. ResultsWe selected 1,125,028 people with type 2 diabetes (44.7% female). The crude incidence was stable. In 2004 the incidence rate was 4.18 cases per 1,000 people, reducing to 4.13/1,000 in 2021. There was a shift in age-specific incidence to earlier age-groups. The crude prevalence showed a marked increase, rising from 2.95% to 5.41%, levelling off slightly in later years. Increases in prevalence were observed in all groups. Northern Ireland consistently had the lowest prevalence, and Wales had a notably higher prevalence, increasing from 3.71% in 2004 to 6.37%. The mean age at diagnosis decreased in females by 5.5 years to 58.5 years, and by 2.5 years in men, to 58.8 years. ConclusionsThe incidence of type 2 diabetes was largely stable over 20 years but there were changes over time in age-specific groups resulting from a shift to earlier onset or earlier diagnosis. The shift to earlier diagnosis was far more pronounced in women than in men. Prevalence increased markedly, but the rate of increase appeared to be leveling-off a little. There were notable differences in the epidemiology of type 2 diabetes between the four constituent countries of the UK. The number of younger people diagnosed with type 2 diabetes remains a concern. GuarantorCraig Currie is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey 96%
- Severe COVID-19 and Diabetes: A Retrospective Cohort Study from Three London Teaching Hospitals 95%
- Ethnic differences in the manifestation of early-onset type 2 diabetes 94%
Similar papers in this journal
- Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study 94%
- Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission 94%
- Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study 92%
Similar papers in this journal
- The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment- study protocol for a cluster-randomised controlled study 94%
- Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol 94%
- Replicating a COVID-19 study in a national England database to assess the generalisability of research with regional electronic health record data 94%
Similar papers in this journal
- Relation of incident Type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland 96%
- Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adults 91%
- The impact of ancestry on performance of type 1 diabetes genetic risk scores: high discrimination performance is maintained in African ancestry populations, but population specific thresholds may improve risk prediction 91%
Similar papers in this journal
- Type 2 diabetes risks and determinants in 2nd generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK 95%
- Subgroups of young type 2 diabetes in India reveal insulin deficiency as a major driver 94%
- Replication and cross-validation of T2D subtypes based on clinical variables: an IMI-RHAPSODY study 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.